GnRH ban extended indefinitely

Regulations restricting the prescribing and supply of puberty-suppressing hormones will be made indefinite. There were due to expire at the end of December.

The Medicines (Gonadotrophin-Releasing Hormone Analogues) (Restrictions on Private Sales and Supplies) Order 2024 will come into force on 1 January 2025 to follow on from the current emergency order. This will be reviewed in 2027.

Information on the implications of this order for prescribers is online.

Other information:

Ban on puberty blockers to be made indefinite on experts’ advice – GOV.UK

Government’s response to the targeted consultation on proposed changes to the availability of puberty blockers – GOV.UK

Clinical guidance news

Latest news

England & Wales: initial August concession price update

The Department of Health and Social Care has published an initial update to the initial list of August concessions. In this update, there are 48 new prices DDA members can download a fully updated spreadsheet of the Aug

New CD guidance for limited companies

The DDA and the Healthcare Distribution Association (HDA) has published joint guidance on the supply of Controlled Drugs to GP practices constituted as a limited company. In summary, two core regulatory requirements apply: Care regulator registra

Dispensing cross subsidy highlighted in rural GP funding critique

The role of dispensing income as a cross subsidy for rural NHS GP funding has been highlighted in a new paper by a think-tank. Noting the funding challenges of delivering NHS GP services in rural areas, General practice funding in England publ

GnRH ban extended indefinitely

Latest news

England & Wales: initial August concession price update

New CD guidance for limited companies

Dispensing cross subsidy highlighted in rural GP funding critique

View all news

Gold Supporters

Follow us

Dispensing Doctors' Association

DDA Best Practice Group

Dispensing Doctors' Association